SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-023233
Filing Date
2023-05-05
Accepted
2023-05-05 16:41:24
Documents
77
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20052523_10q.htm   iXBRL 10-Q 1448284
2 EXHIBIT 31.1 brhc20052523_ex31-1.htm EX-31.1 11596
3 EXHIBIT 31.2 brhc20052523_ex31-2.htm EX-31.2 12380
4 EXHIBIT 32.1 brhc20052523_ex32-1.htm EX-32.1 7164
10 image0.jpg GRAPHIC 126411
11 image1.jpg GRAPHIC 89579
  Complete submission text file 0001140361-23-023233.txt   8574656

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20230331.xsd EX-101.SCH 56110
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20230331_cal.xml EX-101.CAL 76093
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20230331_def.xml EX-101.DEF 298796
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20230331_lab.xml EX-101.LAB 817609
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20230331_pre.xml EX-101.PRE 464419
71 EXTRACTED XBRL INSTANCE DOCUMENT brhc20052523_10q_htm.xml XML 1407820
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 23894561
SIC: 2834 Pharmaceutical Preparations